Related Experiment Videos
Ultrastructural localization of HMB-45 binding sites
G Schaumburg-Lever1, G Metzler, E Kaiserling
1Department of Dermatology, Eberhard-Karls University, Tubingen, Germany.
Abstract:
Three malignant melanomas, two melanoma metastases, two junctional dysplastic nevi, and normal skin were embedded in Lowicryl. Ultrathin sections were incubated with HMB-45 and a gold-labeled anti-mouse antibody. Gold particles indicating the presence of HMB-45 were found in melanosomes Stage 1 and 2 and in the non-melanized portion of melanosomes Stage 3. Melanosomes Stage 4 and melanosome complexes in keratinocytes, as well as in melanophages, were consistently negative. No specific labelling with HMB-45 was seen in eccrine glands of normal skin.
Insights
The HMB-45 antibody targets melanosomes in early stages (1 and 2) and partially melanized Stage 3 melanosomes. It does not label mature melanosomes or melanophages in melanoma and dysplastic nevi.
Area of Science:
- Immunohistochemistry
- Melanoma Research
- Cell Biology
Background:
- The HMB-45 antibody is a marker used in the diagnosis of melanocytic lesions.
- Understanding the precise localization of HMB-45 within melanocytes is crucial for accurate interpretation.
- Previous studies have indicated HMB-45 reactivity in melanomas, but its detailed subcellular localization requires further clarification.
Purpose of the Study:
- To investigate the subcellular localization of the HMB-45 antigen in various melanocytic lesions and normal skin.
- To determine the stage of melanosome development and cellular compartment where HMB-45 is specifically detected.
Main Methods:
- Immunoelectron microscopy was employed to examine ultrathin sections of embedded tissues.
- Samples included malignant melanomas, melanoma metastases, junctional dysplastic nevi, and normal skin.
- Sections were incubated with the HMB-45 antibody followed by a gold-labeled anti-mouse antibody for detection.
Main Results:
- Gold particles, indicating HMB-45 presence, were observed in Stage 1 and Stage 2 melanosomes.
- HMB-45 was also detected in the non-melanized portions of Stage 3 melanosomes.
- Stage 4 melanosomes, melanosome complexes in keratinocytes, and melanophages were consistently negative for HMB-45.
- No specific HMB-45 labeling was found in the eccrine glands of normal skin.
Conclusions:
- The HMB-45 antibody specifically labels early-stage melanosomes and partially melanized melanosomes.
- HMB-45 is not detected in fully mature melanosomes, melanosome complexes, or melanophages.
- These findings refine the understanding of HMB-45's utility as a marker in melanocytic lesion diagnosis.